FilingReader Intelligence
CQ Pharmaceutical now faces 377m yuan asset impairment charges
August 20, 2025 at 09:42 AM UTC•By FilingReader AI
CQ Pharmaceutical Holdings set aside 377.4 million yuan for asset impairment losses in the first half of 2025, including 374.4 million yuan for credit impairment losses and 2.9 million yuan for inventory impairment.
The provisions will reduce the company's net profit and owner's equity by 196.8 million yuan for the period.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
SZSE:000950•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when CQ Pharmaceutical Holding publishes news
Free account required • Unsubscribe anytime